AbCellera Biologics Inc.: common_shares_issued
| Value | {"unit": "shares", "value": 288426514, "concept": "us-gaap:CommonStockSharesIssued"} |
|---|---|
| Period | (as of 2022-12-31) |
| Status | superseded |
| Entity | AbCellera Biologics Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:26:08.451112+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/ddf74473-f9a7-4e19-a2c7-cd7839871407
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001703057-23-000008Retrieved: 2026-08-19T17:26:08.451112+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001703057/common-shares-issued/2022-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/ddf74473-f9a7-4e19-a2c7-cd7839871407
History
- supersedes {"unit": "shares", "value": 286851595, "concept": "us-gaap:CommonStockSharesIssued"} (evidence 0001564590-23-002128)